Stockreport

Sunshine Biopharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]

Sunshine Biopharma Inc.  (SBFM) 
NASDAQ:AMEX Investor Relations: sunshinebiopharma.com/press-releases.html
PDF Net loss: US$4.51m (loss narrowed by 83% from FY 2022). US$0.18 loss per share (improved from US$1.76 loss in FY 2022). All figures shown in the chart above are for [Read more]